A double-negative prostate cancer subtype is vulnerable to SWI/SNF-targeting degrader molecules.

Thienger P, Paassen I, Yao X, Rubin PD, Lehner M, Lillis N, Benjak A, Shah SR, Leung AK, de Brot S, Naveed A, Daniel B, Shi M, Tremblay J, Triscott J, Cassanmagnago GA, Bolis M, Mela L, Beltran H, Chen Y, Piscuoglio S, Yu H, Ng CKY, Quigley DA, Yauch RL, Rubin MA